Wednesday, 4 November 2026
M
Meridian Globe
Live briefing

Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency

Source Nature 生命科学6d ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Science
Region
Global
Language
English
Item ID
science-7a494cc6

Comments 0 comments

No comments yet. Be the first.

Anti-PD1 immunotherapy in MHC-I dysregulated head and neck cancer promotes metastasis via CD8+ T-cell insufficiency · Meridian Globe